DrugDashboards
← Home
Manufacturing facility

Hetero Drugs Limited

A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.

Country
India
Registered address
Unit I, Sy. No. 213, 214 & 255, Bonthapally Village, Gummadidala Mandal,, Sangareddy district, Telangana 502313, India (IND)
Operations here
api manufacture
FDA identifiers
FEI 3003510514 · DUNS 650433076

FDA inspection history

Outcomes of closed FDA inspections at this site (drug and biologic program areas).

  • VAIDrug Quality Assurance2025-05-16
  • VAIDrug Quality Assurance2020-02-14
  • VAIDrug Quality Assurance2018-03-02
  • NAIDrug Quality Assurance2016-02-25
  • VAIDrug Quality Assurance2014-05-02
  • NAIDrug Quality Assurance2010-11-11

Drugs this plant is listed as making

1 distinct drugs across 2 products name this site in their FDA label.

Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.